Colorado MEDtech, Inc. Signs a Letter of Intent to Acquire Ultrasound Imaging Products Company.BOULDER, Colo.--(BW HealthWire)--Oct. 14, 1999-- Colorado MEDtech, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CMED CMED Coordinated Medical Emergency Direction CMED Central Massachusetts Emergency Dispatch ), a Boulder, Colorado-based medical products and services company, announced it signed a letter of intent to acquire CIVCO Medical Instruments Co., Inc. ("CIVCO"). CIVCO, a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. located in Kalona, Iowa, is a leading designer and manufacturer of specialized medical products for ultrasound imaging equipment and procedures and for minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. equipment and procedures. CIVCO's business focuses on supplying innovative product design, manufacturing, distribution and support to the world's leading imaging original equipment manufacturers (OEMs). CIVCO's annualized annualized Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared. revenues are approximately $10 million and it employs approximately 90 people. The proposed transaction will be a stock-for-stock acquisition, and will be accounted for as a pooling of interests Pooling of Interests An accounting method, used in mergers and acquisitions, where the balance sheet items of the two companies are simply added together. Notes: The opposite of pooling of interests is the purchase acquisition method. . Based upon the business plans of Colorado MEDtech and CIVCO, the proposed transaction will be accretive to the earnings of Colorado MEDtech. "We are looking forward to completing the transaction with CIVCO. They are a strong and talented group and their business offers many opportunities for cooperation with our existing businesses, principally our Imaging and Power Systems division and our CMED Catheter and Disposables Technology unit," said John V. Atanasoff, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Colorado MEDtech. "CIVCO's technology and products will give us a further opportunity to strengthen our relationships with our major imaging customers. We look for this transaction to provide further growth opportunities and synergies with our core business units." Victor Wedel we·del intr.v. we·deled, we·del·ling, we·dels To ski on snow by means of wedeln. [Back-formation from wedeln.] Verb 1. , Chairman and CEO of CIVCO, commented, "This is a very dynamic move for CIVCO. Our businesses complement each other very well and offer a wide array of talent, manufacturing, R&D, unique imaging products and a strong, global customer base." The proposed transaction would be Colorado MEDtech's third acquisition in calendar year 1999 and its fifth acquisition in the past three years. Colorado MEDtech, through its wholly owned subsidiaries and operating divisions, is a leading full-service provider of advanced medical products and comprehensive outsourcing services. Forward-Looking Statements Statements in this news release which are not historical facts are forward-looking statements subject to risks and uncertainties which could cause actual results to differ materially from those set forth in or implied by forward-looking statements, including, but not limited to, the risk that the acquisition may not close, the risk that if the acquisition occurs the acquired company cannot be successfully integrated with the Company's existing operations as contemplated by the Company, the risk that the Company will not be able to successfully penetrate the ultrasound equipment and accessory market, and the risk that a downturn in general economic conditions or customer budgets may adversely affect research and development and capital expenditure budgets of potential customers upon which the Company is dependent. These factors are more fully described in the Company's filings with the Securities and Exchange Commission, including its Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended June 30, 1999, copies of which the Company will provide on request. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion